Preclinical studies of an AAV8-CYP4V2 gene therapy VGR-R01 for the treatment of Bietti crystalline dystrophy
Bietti crystalline dystrophy (BCD) is an autosomal recessive disorder caused by loss-of-function mutations in the CYP4V2 gene, characterized by crystal-like lipid deposits in the retina, progressive photoreceptor loss, and retinal pigment epithelium (RPE) deterioration. Currently, there are no appro...
Saved in:
| Main Authors: | Wenjing Luo, Lu Guo, Liang Lu, Nan Huang, Yezheng Tao, Yufei Zhang, Yanrong Cao, Shin-Shay Tian, Xiaoping Zhao, Xi Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050125000555 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biettis’ Crystalline Dystrophy
by: Amar Dev, et al.
Published: (2010-10-01) -
Multicolour Imaging in Bietti's Crystalline Dystrophy
by: Mridhula Sekar, et al.
Published: (2019-10-01) -
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?
by: Brenda Castro, et al.
Published: (2024-01-01) -
Multimodal Imaging Observation in Different Progressive Types of Bietti Crystalline Dystrophy
by: Shengjuan Zhang, et al.
Published: (2022-01-01) -
iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
by: Estelle Berreur, et al.
Published: (2025-06-01)